Showing 16,981 - 17,000 results of 43,740 for search '(( 50 ((ppm decrease) OR (a decrease)) ) OR ( 5 ((mean decrease) OR (nn decrease)) ))', query time: 1.02s Refine Results
  1. 16981
  2. 16982
  3. 16983
  4. 16984
  5. 16985
  6. 16986
  7. 16987
  8. 16988

    Adipose tissue depot volume relationships with spinal trabecular bone mineral density in African Americans with diabetes by Gary C. Chan (4794924)

    Published 2018
    “…Over 5.3 ± 1.4 years, mean vBMD decreased in thoracic/lumbar spine, while mean adipose tissue volumes increased in SAT, IMAT, and PAT, but not VAT depots. …”
  9. 16989

    Differential requirements of NMDAR and VDCC for Aβ-induced declustering of Homer1b and Shank1. by Francesco Roselli (211670)

    Published 2009
    “…NMDA alone significantly reduced Homer (75.1±8.8%, p<0.05) and a further decrease was observed after NMDA+Aβ cotreatment (50.2±5.2% of untreated control). …”
  10. 16990
  11. 16991

    FPR1/2/3 expression changes of blood immune cells after 6-month CPAP treatment. by Yung-Che Chen (381913)

    Published 2019
    “…<p>(A) FPR1 (+) percentage on neutrophil was decreased after > 6-month CPAP treatment. …”
  12. 16992
  13. 16993
  14. 16994
  15. 16995

    Analyses of directed phase lag index (dPLI [44]) for excitatory/inhibitory (E/I) ratios with respect to pyramidal (Pyr) and parvalbumin (PV) populations (<i>A</i>) and Pyr and soma... by Nobuhiko Wagatsuma (494052)

    Published 2025
    “…<p>Black circles and gray pentagons represent the mean values of dPLI from PV to Pyr and from SOM to Pyr populations, respectively. …”
  16. 16996
  17. 16997

    Docking results of effective compounds in TFDM. by Xu Hu (23350)

    Published 2023
    “…</p><p>Results</p><p>21 active components were screened, 158 potential drug targets for the prevention and treatment of CIRI were obtained, 53 main targets were further screened in the protein-protein interaction network, and 106 signal pathways, 76 biological processes, 26 cell components and 50 molecular functions were enriched (P<0.05). Through the compound-target-pathway network, the key compounds that play a role in the prevention and treatment of CIRI, such as acacetin, apigenin and other flavonoids, as well as the corresponding key targets and key signal pathways, such as AKT1, SRC and EGFR were obtained. …”
  18. 16998

    Active compounds screened from TFDM. by Xu Hu (23350)

    Published 2023
    “…</p><p>Results</p><p>21 active components were screened, 158 potential drug targets for the prevention and treatment of CIRI were obtained, 53 main targets were further screened in the protein-protein interaction network, and 106 signal pathways, 76 biological processes, 26 cell components and 50 molecular functions were enriched (P<0.05). Through the compound-target-pathway network, the key compounds that play a role in the prevention and treatment of CIRI, such as acacetin, apigenin and other flavonoids, as well as the corresponding key targets and key signal pathways, such as AKT1, SRC and EGFR were obtained. …”
  19. 16999

    Network of compound-target-pathway. by Xu Hu (23350)

    Published 2023
    “…</p><p>Results</p><p>21 active components were screened, 158 potential drug targets for the prevention and treatment of CIRI were obtained, 53 main targets were further screened in the protein-protein interaction network, and 106 signal pathways, 76 biological processes, 26 cell components and 50 molecular functions were enriched (P<0.05). Through the compound-target-pathway network, the key compounds that play a role in the prevention and treatment of CIRI, such as acacetin, apigenin and other flavonoids, as well as the corresponding key targets and key signal pathways, such as AKT1, SRC and EGFR were obtained. …”
  20. 17000